<DOC>
	<DOCNO>NCT02159976</DOCNO>
	<brief_summary>1 . To compare 10-day sequential therapy 14-day modify bismuth quadruple therapy establish effective first-line regimen eradication Helicobacter pylorus Korea . 2 . To evaluate effect H. pylorus eradication therapy symptom improvement functional dyspepsia</brief_summary>
	<brief_title>Compare Sequential Quadruple Therapy Eradication Helicobacter Pylori Korea</brief_title>
	<detailed_description>Emerging evidence show eradication rate proton pump inhibitor ( PPI ) -based triple therapy first-line treatment Helicobacter pylorus decrease . The reason decrease efficacy PPI-based triple therapy mainly due increase resistance clarithromycin . Sequential therapy seem effective PPI-based triple therapy , however , eradication rate sequential therapy Korea , mostly 80 % , still satisfactory . Modified bismuth quadruple therapy replace metronidazole amoxicillin ( contain PPI , bismuth , tetracycline amoxicillin ) promise regimen antibiotic resistance rate tetracycline amoxicillin relatively low Korea amoxicillin easy take compare metronidazole . Therefore , aim study compare 10-day sequential therapy 14-day modify bismuth quadruple therapy establish effective first-line regimen eradication Helicobacter pylorus Korea . In addition , previous study report H. pylorus infection also associate functional dyspepsia ( FD ) recommend H. pylori eradication patient FD . However , , randomize prospective study Korea , therefore another aim study evaluate effect H. pylorus eradication therapy symptom improvement FD .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Male female Korean Adult ( Aged â‰¥ 18 year ) Patients diagnosis H. pylori infection follow three method positive rapid urease test ( CLOtest ) histologic evidence H. pylorus modify Giemsa stain positive 13Curea breath test Age 18 year Previous eradication treatment H. pylorus Patients take drug could influence study result proton pump inhibitor , H2 blocker , mucosal protective agent antibiotic History gastrectomy Advanced gastric cancer malignancy Abnormal liver function liver cirrhosis Abnormal renal function chronic kidney disease Other severe concurrent diseases Previous allergic reaction study drug Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Helicobacter pylorus</keyword>
</DOC>